doctor with inhalers

Independent professional body guideline

GINA strategy 2021: management of asthma

2021-06-01T13:12:00+01:00By

This Guidelines summary outlines recommendations for the management of asthma in adults, adolescents, and children aged 6–11

AdobeStock_158900630

NICE guideline

NICE asthma guideline: chronic asthma management

2021-04-23T14:55:00+01:00

A practical summary of NICE recommendations on managing chronic asthma in children, young people, and adults, including three management algorithms

Man with inhaler

NICE guideline

NICE asthma guideline: diagnosis and monitoring

2021-04-20T12:45:00+01:00By

A concise summary on the initial assessment, diagnosis, and monitoring of asthma in adults, young people, and children. Includes assessment algorithms

blue lung red circulation outline-min

Independent professional body guideline

GOLD COPD 2021 strategy

2021-02-02T09:28:00+00:00By

A clear summary of GOLD’s 2021 strategy on COPD diagnosis, management, and prevention, including recommendations on COVID-19 and COPD 

AdobeStock_142414773

Independent professional body guideline

BTS/SIGN asthma in pregnancy guideline

2020-08-20T13:08:00+01:00By

This summary focuses on recommendations for the management of asthma in pregnant women, including during labour, and recommendations for breastfeeding mothers

An inhaler in WPG Yellow

Working party guideline/algorithm

Inhaler choice guideline

2020-07-31T08:50:00+01:00By Development group—Usmani Capstick Saleem Scullion

This management algorithm was developed by a multidisciplinary expert panel: Usmani et al and supported by Chiesi Ltd through the provision of a grant for its production.

man with asthma

Independent professional body guideline

BTS/SIGN management of difficult asthma guideline

2020-07-10T00:00:00+01:00By

This brief summary of BTS/SIGN guidance on the assessment and management of difficult asthma includes information on contributory factors and monitoring.

AdobeStock_332747243

NICE guideline

COVID-19 rapid guideline on COPD

2020-04-17T17:02:00+01:00By

The purpose of this summary is to maximise the safety of patients with chronic obstructive pulmonary disease (COPD) during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources. For more detailed information, please refer to the full guideline.

AdobeStock_289304487

NICE guideline

COVID-19 rapid guideline on severe asthma

2020-04-17T13:39:00+01:00By

The purpose of this guideline is to maximise the safety of adults and children with severe asthma during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources.

Coloured pills in grey hands 3x2

NICE guideline

NICE antibiotics for COPD exacerbations guideline

2019-10-14T11:02:00+01:00By

This concise summary covers what to be aware of when considering antimicrobials for an acute exacerbation of COPD to avoid unnecessary prescribing.

Resource hub

  • Inhaler standards and competency document

Educational resources

GSK logo

COPD: LAMA/LABA therapy—Real life case studies

Content funded and provided by GSK

This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200015 V2.0

GSK logo

Why you might want to review patients with COPD receiving a LAMA

Content funded and provided by GSK

This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200013

GSK logo

COPD: Have you done enough to implement guidelines?

Content funded and provided by GSK

This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200012

GSK logo

Why use LAMA/LABAs as initial maintenance therapy in specific COPD patients?

Content funded and provided by GSK

This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200011

GSK logo

LAMA/LABAs as initial maintenance therapy in COPD

Content funded and provided by GSK

This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200010